BCBSM, Inc. et al v. Walgreen Co. et al
Case Number:
1:20-cv-01853
Court:
Nature of Suit:
Judge:
Firms
- Bryan Cave
- Burke Warren
- Crowell & Moring
- Forsgren Fisher
- Holland & Knight
- HWG LLP
- Kilpatrick Townsend
- Morrison & Foerster
- Perkins Coie
- Riley Safer
- Robins Kaplan
- Ropes & Gray
- Salvatore Prescott
- Stein Mitchell
- Vedder Price
- Williams Barber
Companies
- Blue Cross Blue Shield Association
- Blue Cross & Blue Shield of Louisiana
- BlueCross BlueShield of Massachusetts
- Blue Cross Blue Shield of North Dakota
- BlueCross BlueShield of South Carolina
- Cambia Health Solutions Inc.
- Florida Blue
- HealthNow New York Inc.
- Prime Therapeutics LLC
- Regence BlueCross BlueShield
- Walgreens Boots Alliance Inc.
Sectors & Industries:
-
September 30, 2025
Blue Cross Insurers Sanctioned For 2-Year Discovery Drawout
An Illinois federal judge has ordered a host of Blue Cross and Blue Shield insurers to pay the fees and costs Walgreens incurred in an overbilling suit while helping to work through discovery production, which took two years to remediate with a special master.
-
May 24, 2023
Judge Lets Walgreens Try To Shift Some Overbilling Blame
A federal judge in Chicago has refused to let a division of a health insurance company that processes pharmacy benefits out of possibly facing liability in an ongoing lawsuit from insurance companies that accuse Walgreens of having overcharged them for prescription drugs for more than a decade.
-
February 10, 2022
Walgreens OK'd To Pursue Crowell & Moring Breach Claims
An Illinois federal judge on Wednesday refused to throw out Walgreens' allegations that insurers in a prescription pricing dispute are helping Crowell & Moring LLP breach its duties, ruling that the pharmacy chain has plausibly alleged that the insurers knew the firm previously represented Walgreens yet continue to work with it.
-
July 09, 2020
Walgreens Wants Insurers' Overcharging Suit Tossed
Walgreens asked an Illinois federal judge on Wednesday to toss a "misguided" fraud suit accusing it of intentionally overcharging private insurers for prescription drugs, saying the case can't move forward without the pharmacy benefit managers that act as intermediaries in insurers' transactions with pharmacies.